342
Participants
Start Date
March 1, 2021
Primary Completion Date
March 30, 2022
Study Completion Date
March 30, 2022
No intervention
This is an observational study with no intervention.
Nanjing medical university, Nanjing
Lead Sponsor
Nanjing Medical University
OTHER